# Pricing

Try RegLine free for two weeks. Sign up with your credit card and cancel anytime during your trial with no charge. Your selected subscription starts automatically when your trial ends.

### Baseline

For individuals finding relevant records and keeping an eye on their priorities.

$15 — per month · $180 USD billed annually · after your two-week free trial

$18 — per month · billed monthly · after your two-week free trial

**The base plan:**

- Search across letters, approvals, and drug listings, with all filters

- Three saved searches, with daily, weekly, or monthly email alerts

- Detail pages for every letter, approval, and drug listing, with letter PDFs

- Company, product, and pharmacologic-class pages, with timelines

- Home feed, personalization, and suggested searches

- Enforcement report (PDF) over any document source search

### Frontline

For professionals making regulatory research and monitoring part of their everyday work.

$20 — per month · $240 USD billed annually · after your two-week free trial

$24 — per month · billed monthly · after your two-week free trial

Most Popular

**Everything in Baseline, plus:**

- 20 saved searches, up from three

- Competitive briefings: one PDF on up to 5 companies, products or drug classes, with all their letters, approvals and listings

- CSV export of search results and report sections

### Throughline

For individuals whose research spans more brands, companies, and therapeutic areas.

$25 — per month · $300 USD billed annually · after your two-week free trial

$30 — per month · billed monthly · after your two-week free trial

**Everything in Frontline, plus:**

- Unlimited saved searches, up from 20

- Unlimited companies, products, or drug classes in one competitive briefing, up from 5

- Coming soon: API access, MCP access and agent chat

---

**The foundation stays the same**

## Every plan starts with the evidence.

Choose the level of monitoring and reporting that fits your work.

- **FDA source coverage** — Research promotional enforcement letters, Orange and Purple Book records, NDC listings through openFDA, and DailyMed labels.

- **Your priorities, in view** — Personalize your experience around relevant brands, companies, and therapeutic areas.

- **A focused launch** — Search, monitoring, and templated reports. Chat and custom report building are planned for later phases.

---

**Group Plans**

## Interested in Teams or Enterprise?

Individuals in the US can subscribe to RegLine™ using the links above. Interested in a Team or Enterprise plan? [Contact our Sales team](/contact) for a customized proposal.
